Oruka Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Oruka Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Oruka Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$29.4M, a 1420% decline year-over-year.
  • Oruka Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$36.6M, a 405% decline year-over-year.
  • Oruka Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$7.3M, a 31.1% increase from 2022.
  • Oruka Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$10.6M, a 45.2% increase from 2021.
  • Oruka Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$19.3M, a 98% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$36.6M -$29.4M -$27.5M -1420% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$9.13M -$3.12M -$1.15M -58.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$7.98M -$2.48M -$686K -38.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 -$7.3M -$1.59M -$42K -2.71% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-01
Q3 2023 -$7.25M -$1.94M +$615K +24.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-18
Q2 2023 -$7.87M -$1.97M +$1.25M +38.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 -$9.12M -$1.8M +$1.48M +45.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 -$10.6M -$1.55M +$4.13M +72.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-01
Q3 2022 -$14.7M -$2.55M +$2.16M +45.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-18
Q2 2022 -$16.9M -$3.22M +$1.62M +33.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-21
Q1 2022 -$18.5M -$3.28M +$825K +20.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-24
Q4 2021 -$19.3M -$5.68M -$554K -10.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-24
Q3 2021 -$18.8M -$4.72M -$2.73M -137% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 -$16.1M -$4.84M -$3.53M -269% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$12.5M -$4.1M -$2.76M -206% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-02
Q4 2020 -$9.77M -$5.13M -$3.85M -301% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$5.92M -$1.99M -$743K -59.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 -$5.18M -$1.31M +$198K +13.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$5.37M -$1.34M +$441K +24.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$5.81M -$1.28M +$249K +16.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 -$6.06M -$1.25M +$415K +25% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 -$6.48M -$1.51M +$648K +30.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$7.13M -$1.78M +$992K +35.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$8.12M -$1.53M +$2.77M +64.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-18
Q3 2018 -$10.9M -$1.66M +$2.81M +62.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$13.7M -$2.16M +$3.4M +61.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$17.1M -$2.77M +$1.61M +36.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$18.7M -$4.3M -$5K -0.12% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$18.7M -$4.48M +$237K +5.03% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$18.9M -$5.56M -$1.62M -41.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$17.3M -$4.38M -$713K -19.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$16.6M -$4.29M -$1.12M -35.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-22
Q3 2016 -$15.5M -$4.71M -$1.9M -67.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$13.6M -$3.94M -$1.22M -44.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$12.4M -$3.67M -$924K -33.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$11.5M -$3.18M -$563K -21.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-21
Q3 2015 -$10.9M -$2.82M -$532K -23.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$10.4M -$2.72M -$313K -13% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$10M -$2.74M -$354K -14.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$9.69M -$2.61M +$335K +11.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-17
Q3 2014 -$10M -$2.29M -$560K -32.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$9.47M -$2.41M -$1.21M -101% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$8.26M -$2.39M -$1.32M -123% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 -$6.94M -$2.95M -$2.11M -251% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-19
Q3 2013 -$4.83M -$1.73M -$797K -85.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 -$4.04M -$1.2M -$53K -4.63% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$3.98M -$1.07M +$336K +23.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$4.32M -$840K +$794K +48.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-20
Q3 2012 -$5.11M -$928K +$893K +49% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$6.01M -$1.15M +$559K +32.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 -$6.57M -$1.41M +$796K +36.1% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 -$7.36M -$1.63M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-21
Q3 2011 -$1.82M +$285K +13.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 -$1.7M +$565K +24.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q1 2011 -$2.2M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 -$2.11M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$2.27M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.